FDA Approves 1st mRNA Flu Vaccine
Digest more
Moderna's own research shows 5,000 novel jabs required to prevent one hospitalization over standard vaccine. "Pharma finished recapturing" FDA after exit of officials with higher standards, drug industry journalist says.
FDA-approved mFLUSIVA showed better protection against influenza than a conventional flu vaccine while maintaining a comparable safety profile.